Abstract
The diagnostic use of radipharmaceuticals is based on the principle of maximizing medical benefits while minimizing patient risk from radiation exposure. To establish a rational basis for designing nuclear medical procedures, modern dosimetric models take into consideration not only obvious factors such as the type and amount of radionuclide administered, the decay characteristic and radiation spectrum of the nuclide, the physical and biological halflives, etc, but also more subtle factors such as the biokinetics of the radiopharmaceutical, the residence time of the radionuclide in various body compartments, and variations in the intrinsic radiosensitivity of different tissues (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Watson E.E., A.T. Schlafke-Stelson, J.L. Coffey and R.J. Cloutier (Eds): Third International Radiopharmaceutical Dosimetry Symposium. HHS Publication (FDA) 81–8166, Oak Ridger Tennessee, 1981.
Krisch R.E. and M.R. Zelle: Biological effects of radioactive decay. The role of transmutation effect. Advanc. Radiat. Biol. 3:177–213, 1969.
Halpern A. and G. Stoecklin: Chemical and biological consequences of beta-decay. Radiat. and Environm. Biophys. 14:167–183, 257–274, 1977.
Apelgot S. and J.P. Adloff: Transmutation effects of P-32 and P-33 incorporated in DNA. Curr. Top. Radiat. Res. 13:61–95, 1978.
Marin G. and M.A. Bender: A comparison of mammalian cell killing by incorporated 3-H-thymidine and 3-H-uridine. Int. J. Radiat. Biol. 7:235–244, 1963.
Burki H.J. and S. Okada: A comparison of killing of cultured mammalian cells induced by decay of incorporated tritiated molecules at -196 deg.C. Biophys. J. 8:445–456, 1968.
Burki H.J., S. Bunker, M. Ritter and J.E. Cleaver: DNA damage from incorporated radioisotopes: Influence of the 3-H location in the cell. Radiat. Res. 62:299–312, 1975.
Hofer K.G., C.R. Harris and J.M. Smith: Radiotoxicity of intracellular 67-Ga, 125–1 and 3-H: Nuclear versus cytoplasmic radiation effects in murine L1210 leukemia. Int. J. Radiat. Biol. 28: 225–241, 1975.
Warters R.L., K.G. Hofer, C.R. Harris and J.M. Smith: Radionuclide toxicity in cultured mammalian cells: Elucidation of the primary site of radiation damage. Curr. Top. Radiat. Res. Q. 12:389–407, 1977.
Commerford S.L., V.P. Bond, E.P. Cronkite, and U. Reincke: Radiotoxicity of intranuclear 125–1 atoms not bound to DNA. Int. J. Radiat. Biol. 37:347–554, 1980.
Kassis A.I. and S.J. Adelstein: Radiotoxicity of 75-Se and S-35: Theory and application to a cellular model. Radiat. Res. 84:407–425, 1980.
Hofer K.G. and W.L. Hughes: Radiotoxicity of intranuclear tritium, 125-iodine and 131-iodine. Radiat. Res. 47:94–109, 1971.
Feinendegen L.E., H.H. Ertl and V.P. Bond: Biologica toxicity associated with the Auger effect. In: Proceedings of the Symposium on Biophysical Aspects of Radiation Quality (Vienna: IAEA), p. 419, 1971.
Roots R., L.E. Feinendegen and V.P. Bond: Comparative radiotoxicity of 3-H-IUR and 125-IUdR after incorporation into DNA of cultured mammalian cells. In: Proceedings of the Third Symposium on Microdosimetry, edited by H.G. Ebert, p.371. Euratom, 1971.
Burki H.J., R. Roots, L.E. Feinendegen and V.P. Bond: Inactivation of mammalian cells after disintegration of 3-H or 125–1 in cell DNA at -196 deg.C. Int. J. Radiat. Biol. 24:363–375, 1973.
Bradley E.W., P.C. Chan and S.J. Adelstein: The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. Radiat. Res. 63:555–563, 1975.
Chan P.C., E. Lisco, H. Lisco and S.J. Adelstein: The radiotoxicity of iodine-125 in mammalian cells. II. A comparative study on cell survival and cytogenetic responses to 125-IUdR, 131-IUdR, and 3-HTdR. Radiat. Res. 67:332–343, 1976.
Hofer K.G., G. Keough and J.M. Smith: Biological toxicity of Auger emitters: Molecular fragmentation versus electron irradiation. Curr. Top. Radiat. Res. Q. 12:335–354, 1977.
Warters R.L. and K.G. Hofer: Radionuclide toxicity in cultured mammalian cells: Elucidation of the primary site for radiation-induced division delay. Radiat. Res. 69:348–358, 1977.
Kassis A.I., S.J. Adelstein, C. Haydock, K.S.R. Haydock, K.D. McElvany and M.J. Welch: Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. Radiat. Res. 901:362–373, 1982.
Koch C.J. and H.J. Burki: The oxygen enhancement ratio for reproductive death induced by 3-H or 125–I damage in mammalian cells. Int. J. Radiat. Biol. 28:417–425, 1975.
Munson R.J., G.J. Neary, B.A. Bridges and R.J. Preston: The sensitivity of Escherichia coli to ionizing particles of different LETS. Int. J. Radiat. Biol. 13:205–224, 1967.
Berry R.J.: Growing points in mammalian radiobiology and their implications for radiotherapy. Radiol. Clinics N. Amer. 7:281–292, 1969.
Charlton E.E., J. Booz, J. Fidorra, Th. Smit and L.E. Feinendegen: Microdosimetry of radioactive nuclides incorporated into the DNA of mammalian cells. In: Sixth Symposium on Microdosimetry, edited by J. Booz and H.G. Ebert, p.91. London, Harwood Academic Publishers Ltd, 1978.
Hofer K.G.: Toxicity of radionuclides as a function of subcellular dose distribution. In: Third International Radiopharmaceutical Dosimetry Symposium, edited by E.E. Watson, A.T. Schlafke-Stelson, J.L. Coffey and R.J. Cloutier, p.371. HHS Publication (FDA) 81–8166, 1981.
Carlson T.R. and R.M. White: Formation of fragment ions from CH3 Te-125 and C2H2 Te-125 following nuclear decays of CH3 125–I and C2H2 125–I. J. Chem. Phys. 38:2930–2934, 1963.
Stoecklin G.: Chemical and biological effects of beta-decay and inner shell ionization of biomolecules: A new approach to radiation biology. In: Proceedings Sixth Int. Congress Radiat. Res., edited by S. Okada, M. Imamura, T. Terasima, and H. Yamaguchi, p.382. Toppan Printing Co., Ltd., 1979.
Andrews G.A. and C.L. Edwards: Tumor scanning with gallium-67. JAMA 233:1100–1103, 1975.
Hayes R.L.: Factors affecting uptake of radioactive agents by tumor and other tissues, In: Tumor Localization with Radioactive Agents, p.29. IAEA-MG 50/14, 1976.
Staab E.V. and W.H. McCartney: Role of gallium-67 in inflammatory disease. Semin. Nucl. Med. 8:219–234, 1978.
Glickson J.D., R.B. Ryel, M.M. Bordenca, K.H. Kim and R.A. Gams: In vitro binding of 67-Ga to L1210 cells. Cancer Res. 33:2706–2713, 1973.
Goldenberg D.M. (Ed.): Radioimmunodetection of Cancer, p.2957. AUICC Workshop, In: Cancer Res. 40, 1980.
Smith R.T.: Tumor-specific immune mechanisms. N.E.J. Med. 278:1207–1214, 1268–1275, 1311–1326, 1968.
Ghose T. and A. Guclu: Cure of mouse lymphoma with radio-iodinated antibody. Eur. J. Cancer 10:787–792, 1974.
Hofer K.G.: Radiation biology and potential therapeutic applications of radionuclides. Bull. Cancer 67:343–353, 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Hofer, K.G. (1984). Microdosimetry of Labelled Cells. In: Fueger, G.F. (eds) Blood cells in nuclear medicine, part II. Developments in Nuclear Medicine, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6030-5_12
Download citation
DOI: https://doi.org/10.1007/978-94-009-6030-5_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-6032-9
Online ISBN: 978-94-009-6030-5
eBook Packages: Springer Book Archive